Boston Scientific (BSX) said Monday it has entered into a definitive agreement to acquire privately held Valencia Technologies.

The acquisition will expand the company's urology offerings, Boston Scientific said.

The transaction, expected to be completed within H1, will have no material impact on 2026 adjusted earnings per share, the company said.

Financial terms were not provided.